Elizabeth Holmes’ Partner Launches New Venture in Blood Testing Technology

While Elizabeth Holmes remains incarcerated for defrauding investors through her blood-testing company, Theranos, her partner is stepping into the health diagnostics arena with his own enterprise.

Billy Evans, who shares two children with Holmes, is actively seeking investment for Haemanthus, a venture that markets itself as "the future of diagnostics" and promises a transformative approach to health testing.

The parallels to Theranos are notable, as that Silicon Valley startup once captivated global attention by asserting it could perform a wide range of complex laboratory tests using just a finger prick, claims later proven false.

Haemanthus, named after the blood lily flower, intends to initially focus on disease testing in pets before expanding to human diagnostics. Investors familiar with the company’s confidential plans report ambitions to raise upwards of $50 million, with the ultimate objective described as "human health optimization."

Images shared with potential backers reveal a prototype device resembling the notorious Theranos blood-testing machines, featuring a rectangular frame with a door, a digital display, and internally housed tunable lasers as described in the promotional materials.